INVO Fertility, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
INVO Fertility, Inc. (IVF) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $57.86 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-05-15
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-03-31 was $57.86K, a 1.69% increase year-over-year.
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-12-31 was $57.61K, a 23.46% decline year-over-year.
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-03-31 was $56.90K.
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-12-31 was $75.28K.
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $229.02K, a 65.57% increase from fiscal 2021.
- INVO Fertility, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $138.32K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2023-03-31 | $57.86K 10-Q · filed 2023-05-15 | $115.47K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2022-12-31 | $57.61K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $229.02K 10-K · filed 2023-04-17 | ||
| 2022-09-30 | $171.40K 10-Q · filed 2022-11-14 | |||
| 2022-03-31 | $56.90K 10-Q · filed 2023-05-15 | $132.17K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $75.28K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $138.32K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $63.05K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |